De-escalation approaches in the treatment of women with HER2 positive breast cancer need to be personalized, according to an expert.
from Women's Health News -- ScienceDaily http://bit.ly/2J86Otx
Thursday, 2 May 2019
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment